1. 200 Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity by upregulating HER2 in malignant pleural mesothelioma cells. (September 2015) Authors: Okita, R.; Nojima, Y.; Maeda, A.; Yukawa, T.; Saisho, S.; Shimizu, K.; Nakata, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗